Mr Valters and Mr Solzhenitsyn
Mr Valters and Mr Solzhenitsyn
Two of the Claimants’ witnesses were not required to attend for cross-examination. Mr Janis Valters described himself as “the Head of KYC and CDD [i.e., know your client and customer due diligence] for Europe at ECAG”. From the context, it is apparent that “Europe” meant the EU and Switzerland and did not include Russia. Mr Valters’ statement explained the systems EuroChem AG has in place to manage counterparties and payments to them. These systems ensure that payments cannot be made by EuroChem AG to Mr or Mrs Melnichenko. Mr Valters was subordinate to Mr Collishe, who was cross-examined.
The other witness whose evidence was not challenged was Mr Stephan Solzhenitsyn, who has been a member of the EuroChem AG board of directors since 20 December 2021, and Chairman since 9 January 2025. His statement referred to written commitments signed by him on 16 March and 9 June 2022 and confirmed that he has not entered into any agreement or other arrangement, legal or factual, that would allow Mr or Mrs Melnichenko to assert any influence over the conduct of EuroChem AG.
- Heading
- PART A: INTRODUCTION AND PARTIES [1]-[22]
- II: The Claimants [11]-[17]
- III: The Banks and Tecnimont [18]-[20]
- IV: The new Kingisepp plant [21]-[22]
- PART B: THE BONDS AND EUROCHEM NW2’S DEMANDS [23]-[45]
- VI: Designation under Regulation 269 [29]-[33]
- VII: Termination of the Contracts [34]-[37]
- VIII: EuroChem NW2’s demands on the Bonds [38]-[40]
- IX: Rejection of the demands [41]-[45]
- PART C: THE ISSUES AND THE WITNESSES [46]-[98]
- XI: The Claimants’ EuroChem AG witnesses [59]-[66]
- Mr Valters and Mr Solzhenitsyn
- Mr Hechler
- Mr Collishe
- Ms Basyrova
- XII: The Claimants’ EuroChem NW2 witness [67]-[73]
- XIII: The Claimants’ Trust witnesses [74]-[94]
- Mr Fokin
- Mr Noble
- XIV: The Banks’ witnesses [95]-[98]
- PART D: THE FACTS RE OWNERSHIP AND CONTROL [99]-[211]
- The Trusts above EuroChem AG
- The structure from EuroChem AG downwards
- XVI: The ownership structure after sanctions [110]-[123]
- Changes at the level of EuroChem AG
- Changes in directorships
- XVII: Other group structural changes [124]-[144]
- The “Future of EuroChem” memorandum
- The transfers to MCC EuroChem
- The UAE trading cluster
- Changes within EuroChem AG and the EU subsidiaries
- XVIII: Mr Melnichenko’s involvement before March 2022 [145]-[151]
- XIX: The Claimants’ first pleading point [152]-[154]
- XX: The date of the Deed of Retirement [155]-[165]
- XXI: The role of Mrs Melnichenko [166]-[175]
- XXII: Mr Melnichenko’s involvement after March 2022 (1) [176]-[187]
- XXIII: The Claimants’ second pleading point [188]-[197]
- XXIV: Mr Melnichenko’s involvement after March 2022 (2) [198]-[204]
- XXV: The Assignment [205]-[211]
- PART E: REGULATION 269 [212]-[305]
- XXVII: The supplementary EU materials [220]-[225]
- XXVIII: Decisions of the CJEU [226]-[229]
- XXIX: How to interpret Regulation 269 [230]-[240]
- XXX: Article 2(1) [241]-[248]
- XXXI: Article 2(2) [249]-[259]
- XXXII: “Ownership” [260]-[278]
- XXXIII: The Claimants’ third pleading point [279]-[282]
- XXXIV: The MP Bank v Pugachev point [283]-[293]
- XXXV: “Control” [294]-[305]
- PART F: THE NCAS [306]-[347]
- XXXVII: Firewalls and the NCAs [312]-[313]
- XXXVIII: The French NCA: the DGT [314]-[326]
- XXXIX: The Italian NCA: the CSF [327]-[332]
- XL: The Swiss NCA: the SECO [333]-[337]
- XLI: The Cypriot NCA: the SEOK [338]-[341]
- XLII: The Dutch NCA: the BTI [342]-[347]
- PART G: APPLYING REGULATION 269 [348]-[411]
- XLIV: Inferences [360]-[369]
- XLV: Article 2(1) and the Bonds [370]-[378]
- XLVI: The LIA v Maud point [379]-[399]
- XLVII: Article 2(1) and the Assignment [400]
- XLVIII: Article 2(2) and payment to EuroChem NW2 [401]-[403]
- XLIX: Article 2(2) and payment to EuroChem AG [404]-[408]
- L: The pending applications to the DGT and the CSF [409]-[411]
- PART H: REGULATION 833 [412]-[473]
- LII: Are the claims “in connection with” the Contracts? [416]-[429]
- LIII: Are the claims by or on behalf of a Russian entity? [430]-[433]
- LIV: Conclusion on Regulation 833 [434]-[435]
- PART I: THE RULE IN RALLI BROTHERS [436]-[473]
- LVI: The rule in Ralli Brothers [438]-[440]
- LVII: The place of performance under the Bonds [441]-[461]
- LVIII: Licence applications and Article 7 [462]-[465]
- LIX: Public policy [466]-[470]
- LX: Implied term [471]-[472]
- LXI: Conclusion on the rule in Ralli Brothers [473]
- PART J: OTHER ARGUMENTS [474]-[494]
- LXIII: The Bonds’ expiry dates [476]-[478]
- LXIV: Validity of the Assignment [479]-[482]
- LXV: The Assignment and Article 9 [483]-[486]
- LXVI: The sanctioned Russian banks [487]-[491]
- LXVII: ING’s Part 20 claim against Tecnimont [492]-[494]
- Conclusions
![CL-2022-000456 - [2025] EWHC 1938 (Comm)](https://backend.juristeca.com/files/emisores/logo_WAai98v.png)